JP2012522995A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012522995A5 JP2012522995A5 JP2012503731A JP2012503731A JP2012522995A5 JP 2012522995 A5 JP2012522995 A5 JP 2012522995A5 JP 2012503731 A JP2012503731 A JP 2012503731A JP 2012503731 A JP2012503731 A JP 2012503731A JP 2012522995 A5 JP2012522995 A5 JP 2012522995A5
- Authority
- JP
- Japan
- Prior art keywords
- markers
- mammal
- present
- diagnostic disease
- disease score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 32
- 201000010099 disease Diseases 0.000 claims description 23
- 239000012472 biological sample Substances 0.000 claims description 22
- 238000011491 transcranial magnetic stimulation Methods 0.000 claims description 18
- 241000124008 Mammalia Species 0.000 claims description 14
- 230000002503 metabolic effect Effects 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 208000035475 disorder Diseases 0.000 claims description 9
- 230000002757 inflammatory effect Effects 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 4
- 230000000508 neurotrophic effect Effects 0.000 claims description 4
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 230000004797 therapeutic response Effects 0.000 claims description 2
- 230000004044 response Effects 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 1
- 239000000090 biomarker Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 208000024714 major depressive disease Diseases 0.000 description 3
- 230000003542 behavioural effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000009225 cognitive behavioral therapy Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000010320 meditation therapy Methods 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 210000002442 prefrontal cortex Anatomy 0.000 description 2
- 238000013548 repetitive transcranial magnetic stimulation Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16566209P | 2009-04-01 | 2009-04-01 | |
| US61/165,662 | 2009-04-01 | ||
| PCT/US2010/029720 WO2010115061A2 (en) | 2009-04-01 | 2010-04-01 | Biomarkers for monitoring treatment of neuropsychiatric diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012522995A JP2012522995A (ja) | 2012-09-27 |
| JP2012522995A5 true JP2012522995A5 (cg-RX-API-DMAC10.html) | 2013-05-16 |
| JP5675771B2 JP5675771B2 (ja) | 2015-02-25 |
Family
ID=42828950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012503731A Expired - Fee Related JP5675771B2 (ja) | 2009-04-01 | 2010-04-01 | 精神神経疾患の治療をモニタリングするためのバイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100280760A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2414824B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5675771B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN102483398A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2757518A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2010115061A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8158374B1 (en) | 2006-09-05 | 2012-04-17 | Ridge Diagnostics, Inc. | Quantitative diagnostic methods using multiple parameters |
| JP5540000B2 (ja) * | 2008-10-15 | 2014-07-02 | リッジ ダイアグノスティックス，インコーポレイテッド | うつ病性障害のヒトバイオマーカーハイパーマッピング |
| WO2010059709A2 (en) * | 2008-11-18 | 2010-05-27 | Ridge Diagnostics, Inc. | Metabolic syndrome and hpa axis biomarkers for major depressive disorder |
| US20120178118A1 (en) * | 2010-12-06 | 2012-07-12 | Bo Pi | Biomarkers for monitoring treatment of neuropsychiatric diseases |
| CA2757659A1 (en) * | 2009-04-06 | 2010-10-14 | Ridge Diagnostics, Inc. | Biomarkers for monitoring treatment of neuropsychiatric diseases |
| WO2011094308A2 (en) * | 2010-01-26 | 2011-08-04 | Ridge Diagnostics, Inc. | Multiple biomarker panels to stratify disease severity and monitor treatment of depression |
| AU2012329088A1 (en) * | 2011-10-24 | 2014-05-29 | President And Fellows Of Harvard College | Enhancing diagnosis of disorder through artificial intelligence and mobile health technologies without compromising accuracy |
| ES3067417T3 (en) | 2015-08-11 | 2026-05-21 | Cognoa Inc | Apparatus to determine developmental progress with artificial intelligence and user input |
| US11972336B2 (en) | 2015-12-18 | 2024-04-30 | Cognoa, Inc. | Machine learning platform and system for data analysis |
| CN109715194B (zh) | 2016-08-03 | 2024-06-11 | 南佛罗里达大学 | 用于治疗神经障碍的颤蛋白组合物 |
| CN118609834A (zh) | 2016-11-14 | 2024-09-06 | 科格诺亚公司 | 用于评估发育状况并提供覆盖度和可靠性控制的方法和装置 |
| JP7324709B2 (ja) | 2017-02-09 | 2023-08-10 | コグノア，インク． | デジタル個別化医療のためのプラットフォームとシステム |
| CN109568795B (zh) * | 2018-11-23 | 2023-01-24 | 中国医学科学院生物医学工程研究所 | 基于脑电溯源和线性相关的脑深部磁刺激靶点定位方法 |
| CN113873935B (zh) | 2019-03-22 | 2024-11-22 | 科格诺亚公司 | 个性化数字化治疗方法和装置 |
| KR102365373B1 (ko) * | 2019-07-19 | 2022-02-21 | 연세대학교 산학협력단 | 재활 운동에 대한 치료 반응 예측 방법 및 키트 |
| WO2021046412A1 (en) | 2019-09-06 | 2021-03-11 | Cognoa, Inc. | Methods, systems, and devices for the diagnosis of behavioral disorders, developmental delays, and neurologic impairments |
| KR20220167321A (ko) * | 2020-07-02 | 2022-12-20 | 페어 테라퓨틱스 (유에스), 인코포레이티드 | 디지털 치료 위약 및 샴을 생성 및 관리하기 위한 시스템, 방법 및 디바이스 |
| US20240120050A1 (en) * | 2022-10-07 | 2024-04-11 | Insight Direct Usa, Inc. | Machine learning method for predicting a health outcome of a patient using video and audio analytics |
| US20260188467A1 (en) * | 2024-12-27 | 2026-07-02 | Center for Social Dynamics, LLC | Parallel Processing Systems and Methods For Real-Time Multimodal Behavioral Classification Using Neural Networks With Dynamic Content Adaptation |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050123938A1 (en) * | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
| WO2002057790A2 (en) | 2001-01-19 | 2002-07-25 | Mindsense Biosystems Ltd. | Methods and compositions for diagnosing and treating a subject having depression |
| US20040152107A1 (en) * | 2002-09-18 | 2004-08-05 | C. Anthony Altar | Gene signature of electroshock therapy and methods of use |
| US7490085B2 (en) * | 2002-12-18 | 2009-02-10 | Ge Medical Systems Global Technology Company, Llc | Computer-assisted data processing system and method incorporating automated learning |
| US7706871B2 (en) * | 2003-05-06 | 2010-04-27 | Nellcor Puritan Bennett Llc | System and method of prediction of response to neurological treatment using the electroencephalogram |
| US7418290B2 (en) * | 2003-05-06 | 2008-08-26 | Aspect Medical Systems, Inc. | System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram |
| US20050084880A1 (en) * | 2003-07-11 | 2005-04-21 | Ronald Duman | Systems and methods for diagnosing & treating psychological and behavioral conditions |
| JP2005312435A (ja) | 2004-03-29 | 2005-11-10 | Kazuhito Rokutan | うつ病の評価方法 |
| KR20050115436A (ko) | 2004-06-02 | 2005-12-07 | 김은아 | 우울증 치료에 사용되는 '반복적 경두개 자기장 법'에 의하여 발현이 변화되는 흰쥐 뇌의 해마 유전자군. |
| JP2007024822A (ja) * | 2005-07-21 | 2007-02-01 | Aska Pharmaceutical Co Ltd | 男性の更年期又はうつ病の鑑別方法 |
| JP2009516156A (ja) * | 2005-10-18 | 2009-04-16 | ケンブリッジ エンタープライズ リミティッド | 精神病性障害を診断及びモニタリングする方法及びバイオマーカー |
| US8673650B2 (en) | 2005-12-09 | 2014-03-18 | Ridge Diagnostics, Inc. | Optical molecular detection |
| HRP20140673T1 (hr) * | 2006-02-17 | 2014-10-10 | Atsuo Sekiyama | Indikator biološkog materijala i postupak mjerenja biološkog materijala |
| US20080015465A1 (en) * | 2006-06-15 | 2008-01-17 | Scuderi Gaetano J | Methods for diagnosing and treating pain in the spinal cord |
| US7651836B2 (en) * | 2006-08-04 | 2010-01-26 | Hospital Santiago Apóstol | Methods for diagnosis and prognostic of psychiatric diseases |
| US8158374B1 (en) * | 2006-09-05 | 2012-04-17 | Ridge Diagnostics, Inc. | Quantitative diagnostic methods using multiple parameters |
| US20080199866A1 (en) * | 2006-10-10 | 2008-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Snp detection and other methods for characterizing and treating bipolar disorder and other ailments |
| US20080281531A1 (en) | 2007-03-15 | 2008-11-13 | Kazuhito Rokutan | Method for Diagnosing Depression |
| CN102037355A (zh) * | 2008-03-04 | 2011-04-27 | 里奇诊断学股份有限公司 | 基于多重生物标记物板块诊断和监测抑郁症 |
| EP2272044A4 (en) * | 2008-03-12 | 2011-07-06 | Ridge Diagnostics Inc | INFLAMMATORY BIOMARKING FOR MONITORING DEPRESSION DISEASES |
| US20120178118A1 (en) * | 2010-12-06 | 2012-07-12 | Bo Pi | Biomarkers for monitoring treatment of neuropsychiatric diseases |
| CA2757659A1 (en) * | 2009-04-06 | 2010-10-14 | Ridge Diagnostics, Inc. | Biomarkers for monitoring treatment of neuropsychiatric diseases |
| WO2011094308A2 (en) * | 2010-01-26 | 2011-08-04 | Ridge Diagnostics, Inc. | Multiple biomarker panels to stratify disease severity and monitor treatment of depression |
-
2010
- 2010-04-01 JP JP2012503731A patent/JP5675771B2/ja not_active Expired - Fee Related
- 2010-04-01 CA CA2757518A patent/CA2757518A1/en not_active Abandoned
- 2010-04-01 CN CN2010800223067A patent/CN102483398A/zh active Pending
- 2010-04-01 US US12/753,022 patent/US20100280760A1/en not_active Abandoned
- 2010-04-01 WO PCT/US2010/029720 patent/WO2010115061A2/en not_active Ceased
- 2010-04-01 EP EP10759446.7A patent/EP2414824B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012523009A5 (cg-RX-API-DMAC10.html) | ||
| Zhang et al. | Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation | |
| Verber et al. | Biomarkers in motor neuron disease: a state of the art review | |
| Song et al. | DTI measures track and predict motor function outcomes in stroke rehabilitation utilizing BCI technology | |
| Wright et al. | Behavioral, blood and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury | |
| US20170023591A1 (en) | Traumatic Brain Injury and Neurodegenerative Biomarkers, Methods, and Systems | |
| Hiskens et al. | Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy | |
| Fan et al. | Next-generation sequencing of cerebrospinal fluid for the diagnosis of neurocysticercosis | |
| Yang et al. | Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer’s disease | |
| Zhang et al. | COVID-19-associated acute multi-infarct encephalopathy in an asymptomatic CADASIL patient | |
| Su et al. | Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders | |
| CN102933966A (zh) | 阿尔茨海默病的新型诊断制剂 | |
| WO2010115061A2 (en) | Biomarkers for monitoring treatment of neuropsychiatric diseases | |
| WO2020125530A1 (zh) | D-丝氨酸作为标志物在制备抑郁症诊断试剂盒中的应用及抑郁症诊断试剂盒 | |
| US12144583B2 (en) | Diffusion tensor MR to monitor glymphatic system | |
| Müller et al. | Reduced volumes of the external and internal globus pallidus in male heroin addicts: a postmortem study | |
| BR112020023259A2 (pt) | biomarcadores de acidente vascular cerebral no sangue | |
| Khundakar et al. | Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in late-life depression | |
| Myhr et al. | The N orwegian M ultiple S clerosis R egistry and B iobank | |
| Yakimov et al. | Investigation of choroid plexus variability in schizophrenia-spectrum disorders—insights from a multimodal study | |
| Hirata et al. | Humanized anti-RGMa antibody treatment promotes repair of blood-spinal cord barrier under autoimmune encephalomyelitis in mice | |
| Lu et al. | Preoperative serum metabolites and potential biomarkers for perioperative cognitive decline in elderly patients | |
| Badr et al. | Role of multimodal advanced biomarkers as potential predictors of cognitive and psychiatric aspects of Parkinson's disease | |
| Medina et al. | Integrating neuroimaging, biomarkers, and rehabilitation strategies for optimized diagnosis and recovery in traumatic brain injury | |
| McFarlane et al. | DSP-01 conversion from PLS to ALS: a Dutch cohort study. |